Back to medications
Medication monograph

neostigmine

Carbamate Cholinesterase InhibitorsAcetylcholinesterase InhibitorsNeuromuscular Blocking Agent AntidotesCholinesterase InhibitorsParasympathomemetic (Cholinergic) AgentsParasympathomimetic (Cholinergic) AgentsMyasthenia Gravis

Clinical reference

Product monograph

NEOSTIGMINE METHYLSULFATE injection

NEOSTIGMINE METHYLSULFATE injection, solution

Brands & formulations

Family members

NEOSTIGMINE OMEGA

Marketed
1 MGSUBCUTANEOUS, INTRAMUSCULAR, INTRAVENOUSLIQUID[ "neostigmine methylsulfate" ]
Product monograph

NEOSTIGMINE OMEGA

Marketed
0.5 MGINTRAVENOUS, SUBCUTANEOUS, INTRAMUSCULARLIQUID[ "neostigmine methylsulfate" ]
Product monograph

NEOSTIGMINE OMEGA

Marketed
2.5 MGINTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUSSOLUTION[ "neostigmine methylsulfate" ]
Product monograph

NEOSTIGMINE METHYLSULFATE INJECTION USP

Marketed
0.5 MGSUBCUTANEOUS, INTRAVENOUS, INTRAMUSCULARSOLUTION[ "neostigmine methylsulfate" ]
Product monograph

NEOSTIGMINE METHYLSULFATE INJECTION USP

Marketed
1 MGINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSSOLUTION[ "neostigmine methylsulfate" ]
Product monograph

NEOSTIGMINE METHYLSULFATE INJECTION, USP

Marketed
0.5 MGINTRAMUSCULAR, SUBCUTANEOUS, INTRAVENOUSSOLUTION[ "neostigmine methylsulfate" ]
Product monograph

Classification

Chemical class
Carbamate Cholinesterase Inhibitors
Clinical class
Acetylcholinesterase Inhibitors, Neuromuscular Blocking Agent Antidotes
Banks class
Cholinesterase Inhibitors, Parasympathomemetic (Cholinergic) Agents
AHFS family
Parasympathomimetic (Cholinergic) Agents, Myasthenia Gravis